McDonald's press release ( MCD ): Q1 Non-GAAP EPS of $2.83 beats by $0.09 . Revenue of $6.52B (+9.4% Y/Y) beats by $50M . Global comparable sales increased 3.8% for the quarter, with consistently solid comparable sales growth across all segments U.S. increased 3.9% International Operated Markets increased 3.9% International Developmental Licensed Markets increased 3.4% Global Systemwide sales* inc...
McDonald's press release ( MCD ): Q1 Non-GAAP EPS of $2.83 beats by $0.09 . Revenue of $6.52B (+9.4% Y/Y) beats by $50M . Global comparable sales increased 3.8% for the quarter, with consistently solid comparable sales growth across all segments U.S. increased 3.9% International Operated Markets increased 3.9% International Developmental Licensed Markets increased 3.4% Global Systemwide sales* increased 11% (6% in constant currencies) to over $34 billion for the quarter Across 70 loyalty markets, Systemwide sales to loyalty members were over $38 billion for the trailing twelve-month period and over $9 billion for the quarter Shares +1.5% PM. More on McDonald's McDonald's: Value Strategy Holds, But Not A Q1 Catalyst McDonald's: Fundamentally Solid With Rewarding Dividends But Almost Fully Valued McDonald's: On Track To 50,000 Stores And Dividend King Status, But Risks Are Mounting McDonald’s earnings loom as traders bet big on loyalty and supply chain mentions McDonald's Q1 earnings on deck: What to expect
Knight Therapeutics press release ( KHTRF ): Q1 Non-GAAP EPS of $0.13. Revenue of $148.4M. More on Knight Therapeutics Inc. Knight Therapeutics Inc. (GUD:CA) Shareholder/Analyst Call Prepared Remarks Transcript Knight Therapeutics Inc. (GUD:CA) Q4 2025 Earnings Call Transcript Knight Therapeutics announces approval of additional indication for MINJUVI in Brazil Historical earnings data for Knight ...
Knight Therapeutics press release ( KHTRF ): Q1 Non-GAAP EPS of $0.13. Revenue of $148.4M. More on Knight Therapeutics Inc. Knight Therapeutics Inc. (GUD:CA) Shareholder/Analyst Call Prepared Remarks Transcript Knight Therapeutics Inc. (GUD:CA) Q4 2025 Earnings Call Transcript Knight Therapeutics announces approval of additional indication for MINJUVI in Brazil Historical earnings data for Knight Therapeutics Inc. Financial information for Knight Therapeutics Inc.
SEATTLE, May 07, 2026--Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications directly to customers' homes, is expanding access to Novo Nordisk's Ozempic® pill, the only FDA-approved oral GLP-1 medication to treat type 2 diabetes. Amazon Pharmacy will offer Same-Day prescription delivery and pickup within minutes through in-office kiosk locations soon, addressing...
SEATTLE, May 07, 2026--Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications directly to customers' homes, is expanding access to Novo Nordisk's Ozempic® pill, the only FDA-approved oral GLP-1 medication to treat type 2 diabetes. Amazon Pharmacy will offer Same-Day prescription delivery and pickup within minutes through in-office kiosk locations soon, addressing a critical access gap for the more than 36 million Americans living with type 2 diabetes.
Klabin press release ( KLBAY ): Q1 net loss of -R$497M (vs. R$446M in Q1/2025). Net revenue of R$4,946M (+2% Y/Y). More on Klabin Klabin S.A. (KLBAY) Q4 2025 Earnings Call Transcript Klabin S.A. 2025 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Klabin Historical earnings data for Klabin Financial information for Klabin
Klabin press release ( KLBAY ): Q1 net loss of -R$497M (vs. R$446M in Q1/2025). Net revenue of R$4,946M (+2% Y/Y). More on Klabin Klabin S.A. (KLBAY) Q4 2025 Earnings Call Transcript Klabin S.A. 2025 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Klabin Historical earnings data for Klabin Financial information for Klabin
Nexstar Media press release ( NXST ): Q1 GAAP EPS of $5.09 beats by $0.69 . Revenue of $1.39B (+13.0% Y/Y) beats by $130M . First quarter net revenue of $1.40 billion, increased $162 million year-over-year, or 13.1%, primarily due to $106 million of incremental revenue from our acquisition of TEGNA and higher advertising and distribution revenue from our legacy business units. More on Nexstar Medi...
Nexstar Media press release ( NXST ): Q1 GAAP EPS of $5.09 beats by $0.69 . Revenue of $1.39B (+13.0% Y/Y) beats by $130M . First quarter net revenue of $1.40 billion, increased $162 million year-over-year, or 13.1%, primarily due to $106 million of incremental revenue from our acquisition of TEGNA and higher advertising and distribution revenue from our legacy business units. More on Nexstar Media Nexstar Stuck In Limbo As Judge Halts Tegna Integration Nexstar Media's Aim For Scale Drives Instant Value, But Shares No Longer Cheap Nexstar Media Group, Inc. (NXST) Presents at Deutsche Bank 34th Annual Media, Internet & Telecom Conference Transcript Nexstar Media Q1 2026 Earnings Preview Five states join lawsuit to block Nexstar-Tegna deal
Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Kurt Wagner reports on Elon Musk’s settlement with the Securities and Exchange Commission over his purchase of Twitter. Tech Across the Globe Anthropic leases SpaceX data center: The AI company has signed a deal with SpaceX to use more than 300MW of computing capacity at ...
Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Kurt Wagner reports on Elon Musk’s settlement with the Securities and Exchange Commission over his purchase of Twitter. Tech Across the Globe Anthropic leases SpaceX data center: The AI company has signed a deal with SpaceX to use more than 300MW of computing capacity at a massive data center in Memphis. Here’s why Anthropic needs the power . Cheaper crypto: Morgan Stanley is rolling out cryptocurrency trading on its E*Trade platform with a dig at rivals: cheaper pricing. Find out how it’s undercutting Coinbase . Arm’s mixed message: The chip designer warned of sluggishness in the smartphone industry while promising its AI data center business would more than offset the slump. Investors were skeptical . Disney’s results: The entertainment company’s profit and revenue topped Wall Street’s expectations. See what businesses spurred the growth . Revalued Dutch startup QuantWare is raising $178 million to build a production facility for quantum computing processors. Intel’s venture capital arm is leading the fundraising round with Dutch investment firm Forward.one. A variety of startups and large companies are trying to apply quantum physics to make more powerful computers. Twitter drama Imagine your actions cost a group of investors $150 million. You’d probably be worried about a hefty fine. Maybe it would prevent you from running a public company, or mean that you can’t do business with those investors ever again. You’d certainly expect your reputation to take a hit. A misstep like that, even accidental, would come with consequences, surely. Not if your name is Elon Musk . On Monday, Musk agreed to settle a lawsuit with the US Securities and Exchange Commission over allegations that he broke securities law while building his stake in Twitter back in early 2022. As Musk bought shares he later used as leverage to purchase the company, he surpass...
Premium Brands press release ( PRBZF ): Q1 Non-GAAP EPS of $0.83. Revenue of $2.1B. Declared a dividend of $0.85 per common share for the second quarter of 2026 Completed the acquisition of Stampede Culinary Partners Subsequent to the quarter, completed the sale of the Company's 74% interest in Shaw Bakers for US$116.9 million (approximately CA$160 million) consisting of US$106.9 million and a US$...
Premium Brands press release ( PRBZF ): Q1 Non-GAAP EPS of $0.83. Revenue of $2.1B. Declared a dividend of $0.85 per common share for the second quarter of 2026 Completed the acquisition of Stampede Culinary Partners Subsequent to the quarter, completed the sale of the Company's 74% interest in Shaw Bakers for US$116.9 million (approximately CA$160 million) consisting of US$106.9 million and a US$10 million 3-year promissory note bearing interest at 7% per annum Pro-forma total debt to EBITDA ratio decreased to 3.9 : 1 after reflecting the Shaw Bakers transaction More on Premium Brands Holdings Premium Brands: I Waited A Year For This Dip Premium Brands Holdings Corporation (PBH:CA) Q4 2025 Earnings Call Transcript Premium Brands Holdings Corporation 2025 Q4 - Results - Earnings Call Presentation Premium Brands gains as activist investor sees potential 75% upside Historical earnings data for Premium Brands Holdings
Specimen from 1983 lay forgotten at Natural History Museum until recently, when spotted by a volunteer and identified as new genus He has lizards, bats, frogs, weevils, flatworms, snails and spiders named after him . But now Sir David Attenborough can celebrate his 100th birthday with an entirely new genus named in his honour. Scientists from the Natural History Museum in London have paid tribute ...
Specimen from 1983 lay forgotten at Natural History Museum until recently, when spotted by a volunteer and identified as new genus He has lizards, bats, frogs, weevils, flatworms, snails and spiders named after him . But now Sir David Attenborough can celebrate his 100th birthday with an entirely new genus named in his honour. Scientists from the Natural History Museum in London have paid tribute to the world-renowned broadcaster for his 100th birthday on 8 May by describing a new genus of parasitic wasp and a new species found within the museum’s collections. Continue reading...
In this article PTON Follow your favorite stocks CREATE FREE ACCOUNT The Peloton Tread+ and Bike+ during a media preview at Peloton headquarters in New York, US, on Tuesday, Sept. 30, 2025. Gabby Jones | Bloomberg | Getty Images Peloton posted fiscal third-quarter earnings results Thursday that beat Wall Street expectations on revenue but fell slightly short on earnings per share. The company tout...
In this article PTON Follow your favorite stocks CREATE FREE ACCOUNT The Peloton Tread+ and Bike+ during a media preview at Peloton headquarters in New York, US, on Tuesday, Sept. 30, 2025. Gabby Jones | Bloomberg | Getty Images Peloton posted fiscal third-quarter earnings results Thursday that beat Wall Street expectations on revenue but fell slightly short on earnings per share. The company touted growth in equipment sales and subscription revenue as helping to drive its sales and profitability, with free cash flow up nearly 60%. "The first order of business in earnings is reporting how you did financially, and we feel like that was a pretty good quarter in terms of where we are strategically," CEO Peter Stern told CNBC. Here's how the company performed in its quarter ended March 31, compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: 6 cents vs. 7 cents expected Revenue: $630.9 million vs. $617.6 million expected The company's net income for the quarter was $26.4 million, or 6 cents per share, up from a loss of $47.7 million, or 12 cents per share, in the year-ago period. Sales came in at $630.9 million, up roughly 1% from $624 million a year earlier. For the full fiscal year, Peloton said it projects total revenue of between $2.42 billion and $2.44 billion, lifting the lower end of the guidance range it provided last quarter. The company saw revenue for its connected fitness subscriptions come in at $202.9 million, down from $205.5 million a year prior but beating estimates of $196 million, according to StreetAccount. Subscription revenue also beat estimates and grew 2% year over year, reaching $428 million. Paid connected fitness subscriber count, however, fell year over year to 2.66 million. The connected fitness company has been struggling with weak performance and sluggish sales, previously projecting that performance to extend into this quarter. It's tried to revamp its product assortment and recently rai...
Aclaris Therapeutics press release ( ACRS ): Q1 GAAP EPS of -$0.15 beats by $0.01 . Revenue of $2M (+37.0% Y/Y) beats by $0.68M . More on Aclaris Therapeutics Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates - Slideshow Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody ...
Aclaris Therapeutics press release ( ACRS ): Q1 GAAP EPS of -$0.15 beats by $0.01 . Revenue of $2M (+37.0% Y/Y) beats by $0.68M . More on Aclaris Therapeutics Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates - Slideshow Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates Transcript Aclaris Therapeutics GAAP EPS of -$0.16 misses by $0.02, revenue of $1.3M misses by $0.77M Seeking Alpha’s Quant Rating on Aclaris Therapeutics Historical earnings data for Aclaris Therapeutics
Bob's Discount Furniture, Inc. press release ( BOBS ): Q1 Non-GAAP EPS of $0.09. Revenue of $578.1M. Adjusted EBITDA* of $37.6 million or 6.5% compared to $37.3 million or 7.0% in the first quarter of fiscal year 2025. More on Bob's Discount Furniture, Inc. Bob's Discount Furniture: A Compelling 'Buy' After Post-IPO Crash Bob's Discount Furniture, Inc. (BOBS) Q4 2025 Earnings Call Transcript Bob's...
Bob's Discount Furniture, Inc. press release ( BOBS ): Q1 Non-GAAP EPS of $0.09. Revenue of $578.1M. Adjusted EBITDA* of $37.6 million or 6.5% compared to $37.3 million or 7.0% in the first quarter of fiscal year 2025. More on Bob's Discount Furniture, Inc. Bob's Discount Furniture: A Compelling 'Buy' After Post-IPO Crash Bob's Discount Furniture, Inc. (BOBS) Q4 2025 Earnings Call Transcript Bob's Discount Furniture: Discounted Furniture But Not Its Shares Consumer IPO scorecard: Early gains for Yesway; slumps for BRCB, BOBS, and OFRM Bob's Discount Furniture slides after its first post-IPO earnings report